Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
ラクトフェリン製品、腸溶性ラクトフェリン技術
Applicable field (uses covered by this announcement)
妊娠を希望する方および妊娠中の方に対する、子宮内細菌叢の改善、妊娠中の流産・早産リスクの抑制
Relationship between the counterparty and the company
Soiken Holdings Inc.2385
Relationship with the Company
NRLファーマとVarinosが共同で特許を保有する関係。当社はNRLファーマの100％親会社
CounterpartyVarinos株式会社
本社：東京都江東区、代表取締役CEO：桜庭喜行。その他の事業内容・資本金・設立年はNot disclosed
Registration number and expiry date
特許第7580697号。既存の共同特許は特許第6831548号。有効期限はNot disclosed
Impact on Business Performance
当期の業績への影響は軽微であると見込んでいる
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | ラクトフェリン製品、腸溶性ラクトフェリン技術 |
| Counterparty | Varinos株式会社 |
| Counterparty overview | 本社：東京都江東区、代表取締役CEO：桜庭喜行。その他の事業内容・資本金・設立年はNot disclosed |
| Relationship with the Company | NRLファーマとVarinosが共同で特許を保有する関係。当社はNRLファーマの100％親会社 |
| Applicable area | 妊娠を希望する方および妊娠中の方に対する、子宮内細菌叢の改善、妊娠中の流産・早産リスクの抑制 |
| Registration number and expiry date | 特許第7580697号。既存の共同特許は特許第6831548号。有効期限はNot disclosed |
| Impact on Business Performance | 当期の業績への影響は軽微であると見込んでいる |
Items this document does not state (11)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyLocationLocation scaleQuantitative EffectsUsage historySource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.特許取得により、妊娠を希望する方から妊娠中の方まで幅広いサポートが可能になり、ラクトフェリン製品の更なる導入拡大と当社グループの業績・企業価値の向上に資するとしている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.